日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Linking microbial genes to plasma and stool metabolites uncovers host-microbial interactions underlying ulcerative colitis disease course.

将微生物基因与血浆和粪便代谢物联系起来,揭示了溃疡性结肠炎疾病进程中宿主与微生物的相互作用

Schirmer Melanie, Stražar Martin, Avila-Pacheco Julian, Rojas-Tapias Daniel F, Brown Eric M, Temple Emily, Deik Amy, Bullock Kevin, Jeanfavre Sarah, Pierce Kerry, Jin Shen, Invernizzi Rachele, Pust Marie-Madlen, Costliow Zach, Mack David R, Griffiths Anne M, Walters Thomas, Boyle Brendan M, Kugathasan Subra, Vlamakis Hera, Hyams Jeffrey, Denson Lee, Clish Clary B, Xavier Ramnik J

An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections

迭代方法指导FabI抑制剂法比霉素的发现,法比霉素是一种后期抗生素候选药物,对耐药革兰氏阴性菌感染具有体内疗效。

Parker, Erica N; Cain, Brett N; Hajian, Behnoush; Ulrich, Rebecca J; Geddes, Emily J; Barkho, Sulyman; Lee, Hyang Yeon; Williams, John D; Raynor, Malik; Caridha, Diana; Zaino, Angela; Shekhar, Mrinal; Muñoz, Kristen A; Rzasa, Kara M; Temple, Emily R; Hunt, Diana; Jin, Xiannu; Vuong, Chau; Pannone, Kristina; Kelly, Aya M; Mulligan, Michael P; Lee, Katie K; Lau, Gee W; Hung, Deborah T; Hergenrother, Paul J

Correction to "An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections"

对“迭代方法指导发现FabI抑制剂法比霉素,一种对耐药革兰氏阴性菌感染具有体内疗效的后期抗生素候选药物”一文的更正

Parker, Erica N; Cain, Brett N; Hajian, Behnoush; Ulrich, Rebecca J; Geddes, Emily J; Barkho, Sulyman; Lee, Hyang Yeon; Williams, John D; Raynor, Malik; Caridha, Diana; Zaino, Angela; Rohde, Jason M; Zak, Mark; Shekhar, Mrinal; Muñoz, Kristen A; Rzasa, Kara M; Temple, Emily R; Hunt, Diana; Jin, Xiannu; Vuong, Chau; Pannone, Kristina; Kelly, Aya M; Mulligan, Michael P; Lee, Katie K; Lau, Gee W; Hung, Deborah T; Hergenrother, Paul J